Hampton Research蛋白结晶试剂盒
Products > Optimize Reagents > Optimize – Buffers > Imidazole Buffer
Imidazole Buffer
Applications
- Crystallization grade Imidazole for formulating screens or for optimization
Features
- Sterile filtered
- Formulated in Type 1+ ultrapure water: 18.2 megaohm-cm resistivity at 25°C, < 5 ppb Total Organic Carbon, bacteria free (<1 Bacteria (CFU/ml)), pyrogen free (<0.03 Endotoxin (EU/ml)), RNase-free (< 0.01 ng/mL) and DNase-free (< 4 pg/µL)
Description
Imidazole
Synonyms: 1,3-Diaza-2,4-cyclopentadiene or Glyoxaline
C3H4N2
Mr 68.08
CAS Number [288-32-4]
EC Number 206-019-2
Beilstein Registry Number 103853
Merck 14,4912
RTECS NI3325000
MDL Number MFCD00005183
PubChem Substance ID 24880372
Purity ≥ 99.5%
UN Number 2923 8/PG 3
pKa = 6.95
The useful pH range of an Imidazole can be 6.2 – 7.8
HR2-819 is titrated to pH 7.0 using HCl
HR2-819 Measured Conductivity Range: 45.4 – 50.4 mS/cm at 25°C
HR2-819 Measured Refractive Index Range: 1.34836 – 1.34904 at 20°C
Titrate HR2-573 to the desired pH using HCl
HR2-573 Measured pH Range: 10.5 – 10.7 at 25°C
HR2-573 Measured Conductivity Range: 71.1 – 101.5 µS/cm at 25°C
HR2-573 Measured Refractive Index Range: 1.34420 – 1.34440 at 20°C
Ca ≤0.001%
Cd ≤0.0005%
Cl ≤0.005%
Co ≤0.0005%
Cr ≤0.0005%
Cu ≤0.0005%
Fe ≤0.0005%
K ≤0.005%
Mg ≤0.0005%
Na ≤0.005%
Ni ≤0.0005%
Pb ≤0.0005%
SO4 ≤0.005%
Zn ≤0.0005%
Click to Zoom In
CAT NO
HR2-573
NAME
DESCRIPTION
100 mL
PRICE
$85.00
cart quote
CAT NO
HR2-819
NAME
DESCRIPTION
100 mL
PRICE
$101.00
cart quote
Support Material(s)
HR2-573 1.0 M Imidazole SDS
HR2-819 1.0 M Imidazole pH 7.0 SDS
Titration TableCertificate Of Analysis
Related Item(S)
- Hydrochloric acid
- Individual StockOptions Imidazole Reagents
- StockOptions Imidazole Kit
References
1. Structure of apo acyl carrier protein and a proposal to engineer protein crystallization through metal ions. X. Qiu and C. A. Janson. Acta Cryst. (2004). D60, 1545-1554 [doi:10.1107/S0907444904015422].
2. Protein crystallization by surface entropy reduction: optimization of the SER strategy. D. R. Cooper, T. Boczek, K. Grelewska, M. Pinkowska, M. Sikorska, M. Zawadzki and Z. Derewenda. Acta Cryst. (2007). D63, 636-645 [doi:10.1107/S0907444907010931].
Hampton Research, first in crystallization since 1991, developing and delivering crystallization and optimization screens, reagents, plates, and other tools for the crystallization of biological macromolecules, including proteins (antibody), peptides (insulin), and nucleic acids (DNA).
- Products
- Gallery
- My Account
|
|
|
- Contact Us
- Quick Order
- Support
|
- Privacy Policy
- Terms and Conditions
|
- Products
- Gallery
- My Account
- Support
- Contact Us
- Quick Order
- Privacy Policy
- Terms and Conditions
|
|
|
|
|
|
|
© 2021 HAMPTON RESEARCH CORP.
| Website by Skyhound Internet